Ambrx Biopharma Inc.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (A…
Biotechnology
US, La Jolla [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Ambrx Biopharma Inc. has no acquisition track records yet.
M&A Deals · History
Ambrx Biopharma Inc. has no acquisition track records yet.